Dr. Sagar Salave

About

Currently, I am working as a vaccine development scientist at the Vaccine Analytics and Formulation Center (VAFC), Pharmaceutical Chemistry Department, The University of Kansas, USA. I have also good expertise in the development and characterization of various nanomedicines for protein and peptide-based biomolecules.
Previously, I was working on lyophilization of small molecules and ophthalmic dosage forms at Ciron Drugs Ltd.
In LUPIN Research Park, I have worked on solid orals as well as ophthalmic dosage forms for the regulatory market.

Employment

• Vaccine Analytics and Formulation Center, University of Kansas Post Doctoral Researcher
  2023 - Present
• Ciron Drugs and Pharmaceuticals Pvt Ltd F&D Officer
  2019 - 2019
• Lupin Ltd Research and Development Trainee Research Executive
  2018 - 2019
• Lupin Ltd Research and Development Project Trainee
  2017 - 2018

Education

• Appasaheb Birnale College of Pharmacy B. Pharm
  2012 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (88)

• Liposomal Delivery of Hepatoprotective Phytochemicals for Liver Diseases: Advances in Formulation, Targeted Delivery, and Clinical Translation
  Biomedicines 2026 DOI: 10.3390/biomedicines14091946
  +Save
• Development of a New Lyophilized Live-Attenuated Measles-Rubella (MR) Vaccine Formulation Designed for Lower Cost Production in Africa [version 1]
  2026 DOI: 10.12688/verixiv.3646.1
  +Save
• Chitosan Nanoparticles in Pulmonary Drug Delivery: Unleashing the Potential for Targeted and Effective Therapy
  Chemistry & Biodiversity 2026 DOI: 10.1002/cbdv.71478
  +Save
• Lipid Nanoparticle-based mRNA Therapeutics for Infectious Diseases
  International Journal of Pharmaceutics 2026 DOI: 10.1016/j.ijpharm.2025.126420
  +Save
• Case Study on Formulating a Multidose Lyophilized Measles-Rubella (MR) Vaccine Candidate for Local Manufacturing in Africa: Lab-Scale Results and Lessons-Learned for Future Technology Transfer [version 1]
  2026 DOI: 10.12688/verixiv.3696.1
  +Save
• Protein and Peptide Therapeutics: Stability Challenges, Regulatory Demands, and Innovative Formulation Solutions for Enhanced Clinical Effectiveness
  Protein and Peptide Letters 2025 DOI: 10.2174/0109298665375151250626124048
  +Save
• Zein: Potential biopolymer in inflammatory bowel diseases
  Journal of Biomedical Materials Research Part A 2025 DOI: 10.1002/jbm.a.37785
  +Save
• Inulin: A Versatile Polymer in Colon Drug Targeting
  Inulin for Pharmaceutical Applications 2025 DOI: 10.1007/978-981-97-9056-2_12
  +Save
• Inulin: A Versatile Polymer in Colon Drug Targeting
  Inulin for Pharmaceutical Applications A Versatile Biopolymer 2025 DOI: 10.1007/978-981-97-9056-2_12
  +Save
• Exosomes nanovesicles for gene delivery and vaccination
  Exosome Communication 2025 DOI: 10.1016/b978-0-443-29052-7.00013-1
  +Save